Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence
NCT00190567 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2007-01-26
Summary
Double-blind placebo-controlled study of the biomechanical effects of duloxetine compared with placebo in the treatment of women with pure genuine stress incontinence
Conditions
- Urinary Stress Incontinence
Interventions
- DRUG
-
duloxetine
- DRUG
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Call 1-877-CTLILLY(1-877-285-4559) or 1-317-615-4559 Mon -Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-31
- Completion
- 2006-04-30
Countries
- United States
Study Locations
More Related Trials
-
Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.
NCT00190905 ·Status: COMPLETED ·Phase: PHASE4
-
To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms
NCT00244296 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence
NCT00190632 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Stress Urinary Incontinence Study
NCT00475358 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence
NCT00190645 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Stress Urinary Incontinence Efficacy and Safety Study
NCT00475397 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Phase III Duloxetine Study for Stress Urinary Incontinence
NCT00191204 ·Status: COMPLETED ·Phase: PHASE3
-
Urge Incontinence Bladder Overactivity Study
NCT00475696 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
NCT00196404 ·Status: COMPLETED ·Phase: PHASE2
-
Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study
NCT04412876 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of V117957 in Overactive Bladder Syndrome
NCT06024642 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence
NCT05674045 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence
NCT04227184 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
NCT01515865 ·Status: COMPLETED ·Phase: PHASE4
-
Bladder Antimuscarinic Medication and Accidental Bowel Leakage
NCT03543566 ·Status: COMPLETED
-
Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia
NCT01357356 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4
NCT01900704 ·Status: COMPLETED ·Phase: PHASE3
-
A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder
NCT03566134 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
NCT01340066 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SSR240600C Treatment in Women With Overactive Bladder
NCT00564226 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
NCT00335660 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
NCT00909181 ·Status: COMPLETED ·Phase: PHASE3
-
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
NCT05878951 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
NCT00332319 ·Status: TERMINATED ·Phase: PHASE2
-
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
NCT04090190 ·Status: COMPLETED ·Phase: PHASE4